Concepedia

Giuseppe Mesiti

GM

Statistics

Publications

12

Citations

692

H-Index

12

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

IRBM Science Park

Sapienza University of Rome

United States Military Academy

University of Pisa

Giuseppe Mesiti is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, medicine, and molecular oncology.

Publications per year

2007–2016

12

Publications

12

Comparative expression pathway analysis of human and canine mammary tumors

Paolo Uva, Luigi Aurisicchio, James Watters et al. · BMC Genomics · 2009 · 195 citations · Full text

Medicine, Cancer Biology, Oncology +17

Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model

Clay L. Efferson, Christopher T. Winkelmann, Christopher Ware et al. · Cancer Research · 2010 · 92 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Vaccine Targeting Telomerase Enhances Survival of Dogs Affected by B-cell Lymphoma

Daniela Peruzzi, Alessandra Gavazza, Giuseppe Mesiti et al. · Molecular Therapy · 2010 · 72 citations · Full text

Medicine, Immunology, Oncology +16

Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment

Rita Mancini, Enrico Giarnieri, Claudia De Vitis et al. · PLoS ONE · 2011 · 68 citations · Full text

Medicine, Cell Biology, Oncology +14

A Novel Series of Potent and Selective Ketone Histone Deacetylase Inhibitors with Antitumor Activity in Vivo

Philip Jones, Sergio Altamura, Raffaele De Francesco et al. · Journal of Medicinal Chemistry · 2008 · 59 citations · Full text

Medicine, Medicinal Chemistry, Oncology +9

1–5 of 12